It is a pharma private limited company based in Dewas, Madhya Pradesh, India, established in 1997.
1997 | Dewas, Madhya Pradesh, India | ActiveKshipra Drugs Private Limited, a active private limited company, was established on 21 April 1997 in Dewas, Madhya Pradesh, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U27105MP1997PTC011846. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹9.20 M.
Formerly known as Kshipra Metals Private Limited. It upholds a compliant status. Its leadership includes Joginder Prasad Pandit (Director), Jitendra Prasad (Director). Past directors included Niranjan Prasad, Prabhu Dayal Sharma. It holds ₹1.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 151 Biodia A.B. Road,, Dewas, Madhya Pradesh.
U27105MP1997PTC011846
011846
21 April 1997
₹1.00 Cr
₹9.20 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Kshipra Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Joginder Prasad Pandit | Director | 21 Apr 1997 | Current |
| Jitendra Prasad | Director | 09 Feb 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Feb 2019 | Past |
| Pramod Abcsdd | Director | 24 Dec 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kshipra Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 61.42% increase. The company also saw a substantial improvement in profitability, with a 31.55% increase in profit. The company's net worth moved up by a moderate rise of 3.07%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Kshipra Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹10,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Nov 2003 | Bank Of India | ₹1.00 M | Open |
| 10 Feb 2003 | Bank Of India | ₹9.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Kshipra Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kshipra Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kshipra Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Kshipra Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Kshipra Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was recorded as a recent event.
Progress on Jitendra Prasad was appointed as a Director was appointed as a Director on 09 Feb 2019 & has been associated with this company since 6 years 10 months . was documented.
The activity A charge with Bank Of India of Rs. 0.90 Cr registered on 10 Feb 2003 with Charge ID 90209202 was modified on 22 Nov 2017. was completed.
The activity A charge with Bank Of India amounted to Rs. 0.10 Cr with Charge ID 90209404 was registered on 24 Nov 2003. was completed.
The activity A charge with Bank Of India amounted to Rs. 0.90 Cr with Charge ID 90209202 was registered on 10 Feb 2003. was completed.
The CIN of Kshipra Drugs Private Limited is U27105MP1997PTC011846.
Kshipra Drugs Private Limited is headquartered at 151 Biodia A.B. Road,, Dewas, Madhya Pradesh.
Kshipra Drugs Private Limited was incorporated on 21 April 1997.
The current directors of Kshipra Drugs Private Limited are
The primary industry of Kshipra Drugs Private Limited is Hospital And Medical Care.
Kshipra Drugs Private Limited is unlisted.
The authorized capital of Kshipra Drugs Private Limited is ₹1.00 Cr, and the paid-up capital is ₹9.20 M.
The compliance status of Kshipra Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX